Results 181 to 190 of about 1,566,141 (255)

Progress in AAV-Mediated In Vivo Gene Therapy and Its Applications in Central Nervous System Diseases. [PDF]

Int J Mol Sci
Wang S, Xiao L.
europepmc   +1 more source

Intercellular mitochondrial transfer in the brain, a new perspective for targeted treatment of central nervous system diseases. [PDF]

CNS Neurosci Ther, 2023
Geng Z, Guan S, Wang S, Yu Z, Liu T, Du S, Zhu C.   +6 more
europepmc   +1 more source

Impact of Kaposi‚s sarcoma in occurrence of opportunistic central nervous system disease

, 1999
Murielle Mary‐Krause, Eric Billaud
openalex   +1 more source

Ozone: complicated effects in central nervous system diseases. [PDF]

Med Gas Res
Zhang X, Wang SJ, Wan SC, Li X, Chen G.
europepmc   +1 more source

Machine learning assisted-nanomedicine using magnetic nanoparticles for central nervous system diseases. [PDF]

Nanoscale Adv, 2023
Tomitaka A, Vashist A, Kolishetti N, Nair M.   +3 more
europepmc   +1 more source

Research progress on the role of ginsenoside Rd in central nervous system diseases. [PDF]

Afr Health Sci
Ma X, Wang J.
europepmc   +1 more source

ACSL4-Mediated Ferroptosis and Its Potential Role in Central Nervous System Diseases and Injuries. [PDF]

Int J Mol Sci, 2023
Jia B, Li J, Song Y, Luo C.
europepmc   +1 more source

Free radical mechanisms and therapeutic potentials of ischemic and degenerative diseases in the central nervous system

, 1996
Kōki Abe
openalex   +1 more source

Oxazole-Based Ferroptosis Inhibitors with Promising Properties to Treat Central Nervous System Diseases. [PDF]

J Med Chem
Scarpellini C, Klejborowska G, Lanthier C, Toye A, Musiałek K, Van San E, Walravens M, Berg M, Hassannia B, Van der Veken P, De Winter H, Vanden Berghe T, Augustyns K.   +12 more
europepmc   +1 more source

Transnasal targeted delivery of therapeutics in central nervous system diseases: a narrative review. [PDF]

Front Neurosci, 2023
Won S, An J, Song H, Im S, You G, Lee S, Koo KI, Hwang CH.   +7 more
europepmc   +1 more source